Skip to main content
Clinical Trials/EUCTR2012-000333-40-NL
EUCTR2012-000333-40-NL
Active, not recruiting
Not Applicable

Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study) - Microbubbles and Iodine seeds in Breast cancer: MIB study

niversity Medical Center Utrecht0 sites120 target enrollmentJuly 24, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patient with breast cancer with an indication for sentinel lymph node biopsy
Sponsor
niversity Medical Center Utrecht
Enrollment
120
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 24, 2012
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Females, aged 18 years or older;
  • \- Histologically confirmed invasive carcinoma or patients with in situ breast cancer with indication for SLN biopsy;
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 80
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 40

Exclusion Criteria

  • \- Male patients;
  • \- Histologically or cytologically proven axillary lymph node involvement;
  • \- Recurrent disease;
  • \- Indication for ALND;
  • \- Pregnancy or lactation;
  • \- Sentinel lymph node biopsy after neoadjuvant treatment;
  • \- Recent acute coronary syndrome or unstable ischemic heart disease\*;
  • \- Severe lung disease\* and shortness of breath;
  • \- Unstable neurologic disease, acute endocarditis, artificial heart valves, acute systemic infection, tromboembolic disease, advanced liver or kidney failure;
  • \- Mentally incompetent patients.

Outcomes

Primary Outcomes

Not specified

Similar Trials